시장보고서
상품코드
1951652

연속 바이오 제조 스키드 시장 보고서(2026년)

Continuous Bio-Manufacturing Skid Global Market Report 2026

발행일: | 리서치사: The Business Research Company | 페이지 정보: 영문 250 Pages | 배송안내 : 2-10일 (영업일 기준)

    
    
    




■ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송일정은 문의해 주시기 바랍니다.

연속 바이오 제조 스키드 시장 규모는 최근 빠르게 확대하고 있습니다. 2025년 19억 9,000만 달러에서 2026년에는 22억 6,000만 달러로, CAGR 13.6%로 성장할 것으로 예상됩니다. 지난 수년간의 성장에는 바이오의약품 생산량 증가, 일괄 처리에서 연속 처리로의 조기 전환, 모듈식 제조 개념의 채택 확대, 백신 및 효소 생산 시설의 확장, 유연한 제조 체제에 대한 수요 증가 등이 주요 요인으로 꼽히고 있습니다.

연속 바이오 제조 스키드 시장 규모는 향후 몇 년간 급속한 성장이 전망됩니다. 2030년에는 37억 3,000만 달러에 달하고, CAGR은 13.3%가 될 전망입니다. 예측 기간 동안 성장 요인으로는 완전 연속형 바이오의약품 생산 도입 확대, 첨단 바이오 공정 자동화에 대한 투자 증가, 신속한 스케일업 능력에 대한 수요 증가, 세포 및 유전자 치료제 생산 확대, 비용 효율적인 바이오의약품 생산에 대한 집중 강화 등을 꼽을 수 있습니다. 예측 기간 동안 주요 동향으로는 연속 및 통합 바이오 공정 스키드 도입 증가, 모듈식 및 플러그 앤 플레이 제조 시스템에 대한 수요 증가, 실시간 공정 모니터링 및 제어 기술의 확산, 일회용 연속 바이오 제조 플랫폼의 확대, 공정 효율성과 공정 효율과 처리량에 대한 집중 강화 등을 들 수 있습니다.

바이오의약품에 대한 수요 증가는 향후 몇 년 동안 연속식 바이오 제조 스키드 시장의 성장을 견인할 것으로 예상됩니다. 바이오의약품은 단백질, 핵산, 생세포 등 생물학적 자원을 이용하여 개발된 의약품으로 질병의 치료, 예방, 진단을 목적으로 하는 의약품입니다. 바이오의약품 수요 확대는 주로 효과적인 치료와 관리를 위해 고도의 생물학적 요법을 필요로 하는 만성질환과 유전성 질환의 유병률 증가에 의해 촉진되고 있습니다. 연속 바이오 제조 스키드는 복잡한 치료제 개발의 효율성, 일관성, 속도를 향상시키는 간소화된 자동화 및 확장 가능한 프로세스를 제공함으로써 바이오의약품 생산을 개선합니다. 예를 들어, 미국에 본사를 둔 헬스케어 기업 Cardinal Health에 따르면 2023년 1월 기준 미국에서는 2023년까지 40개의 FDA 승인 바이오시밀러 제품이 존재하며, 그 중 25개 제품이 시장에 출시될 것으로 예상했습니다. 반면, 2022년 1월 기준 FDA 승인 바이오시밀러는 33개 품목이며, 이 중 시판 중인 제품은 21개 품목입니다. 이처럼 바이오의약품에 대한 수요 증가가 연속식 바이오 제조 스키드 시장의 성장을 견인하고 있습니다.

연속 바이오 제조 스키드 시장의 주요 기업들은 효율성, 확장성, 제품 품질 향상을 위해 첨단 바이오의약품 제조 플랫폼과 같은 혁신적인 솔루션 개발에 주력하고 있습니다. 첨단 바이오의약품 제조 플랫폼은 실시간 모니터링, 효율성 향상, 일관된 제품 품질을 갖춘 바이오의약품의 완전 통합형 연속 생산을 가능하게 하는 첨단 시스템입니다. 예를 들어, 2024년 10월, 인도에 본사를 둔 위탁개발생산기관(CDMO)인 엔젠 바이오사이언시스(Enzene Biosciences)는 CPHI 밀라노 2024에서 생물학적 제제를 위한 차세대 완전연결연속생산(FCCM) 기술인 'EnzeneX 2.0'을 발표했습니다. 이 특허 받은 플랫폼은 관류 배양에서 최종 원료의약품까지 끊김 없이 원활하게 처리할 수 있는 특허 받은 플랫폼입니다. 고역가 클론의 활용과 최적화된 세포배양 배지를 통해 생산성 향상, 표적 단백질 농도 증가, 배치 간 변동성 감소를 실현합니다. 또한, 공정 분석 기술(PAT)을 통합하여 실시간 모니터링 및 제어를 가능하게함으로써 일관된 품질과 운영 효율성을 보장하고 그램당 제조 비용을 최대 50%까지 절감할 수 있습니다. 이 플랫폼은 다양한 양식과 배지 구성에 적응할 수 있는 확장성 및 비용 효율적인 바이오의약품 제조를 제공합니다.

자주 묻는 질문

  • 연속 바이오 제조 스키드 시장 규모는 어떻게 변화하고 있나요?
  • 연속 바이오 제조 스키드 시장의 성장 요인은 무엇인가요?
  • 바이오의약품 수요 증가는 연속 바이오 제조 스키드 시장에 어떤 영향을 미치고 있나요?
  • 연속 바이오 제조 스키드 시장의 주요 기업들은 어떤 혁신적인 솔루션을 개발하고 있나요?
  • 연속 바이오 제조 스키드의 주요 기술적 특징은 무엇인가요?

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 공급망 분석

제4장 세계 시장 동향과 전략

제5장 최종 이용 산업 시장 분석

제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의가 공급망에 미치는 영향, 코로나가 시장에 미치는 영향을 포함한 거시경제 시나리오

제7장 세계의 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석

제8장 시장에서 세계의 총 잠재 시장 규모(TAM)

제9장 시장 세분화

제10장 지역별, 국가별 분석

제11장 아시아태평양 시장

제12장 중국 시장

제13장 인도 시장

제14장 일본 시장

제15장 호주 시장

제16장 인도네시아 시장

제17장 한국 시장

제18장 대만 시장

제19장 동남아시아 시장

제20장 서유럽 시장

제21장 영국 시장

제22장 독일 시장

제23장 프랑스 시장

제24장 이탈리아 시장

제25장 스페인 시장

제26장 동유럽 시장

제27장 러시아 시장

제28장 북미 시장

제29장 미국 시장

제30장 캐나다 시장

제31장 남미 시장

제32장 브라질 시장

제33장 중동 시장

제34장 아프리카 시장

제35장 시장 규제 상황과 투자 환경

제36장 경쟁 구도와 기업 개요

제37장 기타 주요 기업과 혁신적 기업

제38장 세계의 시장 경쟁 벤치마킹과 대시보드

제39장 주요 인수합병

제40장 시장 잠재력이 높은 국가, 부문, 전략

제41장 부록

KSM 26.03.17

A continuous bio-manufacturing skid is a compact, pre-assembled system engineered to perform continuous production of biologics, incorporating unit operations such as fermentation, purification, and formulation into a unified workflow. It facilitates automated, scalable, and efficient biomanufacturing while reducing manual intervention and process variability.

The main product types of continuous bio-manufacturing skids include single-use skids, multi-use skids, and modular skids. Single-use skids are fully integrated, disposable systems designed for the continuous production of biologics, where all product-contacting components are single-use, reducing the risk of cross-contamination and the need for cleaning while supporting uninterrupted upstream or downstream processing. These skids accommodate various processes such as upstream, downstream, and integrated operations. They are applied in a wide range of areas, including biopharmaceutical production, vaccine manufacturing, enzyme production, cell and gene therapy, and more, and cater to diverse end users, including pharmaceutical companies, biotechnology firms, contract manufacturing organizations, research institutes, and other users.

Tariffs are influencing the continuous bio-manufacturing skid market by increasing costs of imported stainless steel components, automation systems, sensors, pumps, and filtration modules used in upstream, downstream, and integrated skids. Biopharmaceutical manufacturers in North America and Europe are most affected due to reliance on imported skid assemblies, while Asia-Pacific faces pricing pressure on export-oriented skid fabrication. These tariffs are increasing upfront system costs and slowing facility expansion decisions. However, they are also driving regional skid manufacturing, localized system integration, and innovation in standardized and cost-optimized continuous biomanufacturing solutions.

The continuous bio-manufacturing skid market research report is one of a series of new reports from The Business Research Company that provides continuous bio-manufacturing skid market statistics, including continuous bio-manufacturing skid industry global market size, regional shares, competitors with a continuous bio-manufacturing skid market share, detailed continuous bio-manufacturing skid market segments, market trends and opportunities, and any further data you may need to thrive in the continuous bio-manufacturing skid industry. This continuous bio-manufacturing skid market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The continuous bio-manufacturing skid market size has grown rapidly in recent years. It will grow from $1.99 billion in 2025 to $2.26 billion in 2026 at a compound annual growth rate (CAGR) of 13.6%. The growth in the historic period can be attributed to growth in biologics production volumes, early transition from batch to continuous processing, rising adoption of modular manufacturing concepts, expansion of vaccine and enzyme production facilities, increasing demand for flexible manufacturing setups.

The continuous bio-manufacturing skid market size is expected to see rapid growth in the next few years. It will grow to $3.73 billion in 2030 at a compound annual growth rate (CAGR) of 13.3%. The growth in the forecast period can be attributed to increasing deployment of fully continuous biologics production, rising investments in advanced bioprocess automation, growing demand for rapid scale-up capabilities, expansion of cell and gene therapy manufacturing, increasing focus on cost-efficient biologics production. Major trends in the forecast period include increasing adoption of continuous and integrated bioprocessing skids, rising demand for modular and plug-and-play manufacturing systems, growing use of real-time process monitoring and control, expansion of single-use continuous biomanufacturing platforms, enhanced focus on process efficiency and throughput.

The rising demand for biopharmaceuticals is expected to drive the growth of the continuous bio-manufacturing skid market in the coming years. Biopharmaceuticals are medicinal products developed using biological sources, such as proteins, nucleic acids, or living cells, to treat, prevent, or diagnose diseases. The growing demand for biopharmaceuticals is mainly fueled by the increasing prevalence of chronic and genetic disorders, which require advanced biologic therapies for effective treatment and management. Continuous bio-manufacturing skid improves biopharmaceutical production by providing streamlined, automated, and scalable processes that enhance efficiency, consistency, and speed in developing complex therapies. For example, in January 2023, according to Cardinal Health Inc., a US-based healthcare company, the U.S. had 40 FDA-approved biosimilar products by 2023, with 25 available on the market. In comparison, as of January 2022, there were 33 FDA-approved biosimilars, of which 21 were commercially available. Thus, the rising demand for biopharmaceuticals is fueling the growth of the continuous bio-manufacturing skid market.

Major companies in the continuous bio-manufacturing skid market are concentrating on developing innovative solutions, such as advanced biologics manufacturing platforms, to improve efficiency, scalability, and product quality. Advanced biologics manufacturing platforms are sophisticated systems that enable fully integrated, continuous production of biologics with real-time monitoring, enhanced efficiency, and consistent product quality. For example, in October 2024, Enzene Biosciences Ltd., an India-based contract development and manufacturing organization, introduced EnzeneX 2.0 at CPHI Milan 2024, the next generation of its fully connected continuous manufacturing (FCCM) technology for biologics. This patented platform allows seamless, uninterrupted processing from perfusion to final drug substance. By utilizing high-titer clones and optimized cell media, it boosts productivity, increases target protein concentrations, and reduces batch-to-batch variability. The system also integrates process analytical technology (PAT) for real-time monitoring and control, ensuring consistent quality and operational efficiency, while providing up to a 50% reduction in production costs per gram. These platforms offer scalable, cost-effective biologics manufacturing that can be adapted to various modalities and media formulations.

In June 2023, Donaldson Company Inc., a US-based filtration technology firm, acquired Univercells Technologies for $159 million (€136 million). Through this acquisition, Donaldson intends to broaden its life sciences portfolio by incorporating Univercells Technologies' innovative single-use bioreactors and automated upstream platforms to provide comprehensive and advanced biomanufacturing solutions for cell and gene therapies, vaccines, and other biologics. Univercells Technologies S.A. is a Belgium-based company offering advanced biomanufacturing solutions that utilize intensified and integrated continuous processing principles.

Major companies operating in the continuous bio-manufacturing skid market are Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Garrett Industrial Systems Ltd., Sartorius AG, Getinge AB, ZETA GmbH, Pall Corporation, Repligen Corporation, ABEC Inc., Enzene Biosciences Limited, Pierre Guerin Technologies, Bioengineering AG, KeyPlants GmbH, G&G Technologies Pvt. Ltd., Scigenics Pvt. Ltd, Exentec B.V., PAK BioSolutions Inc., Stobbe Pharma GmbH, CPi Biotech Inc.

North America was the largest region in the continuous bio-manufacturing skid market in 2025. The regions covered in the continuous bio-manufacturing skid market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the continuous bio-manufacturing skid market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The continuous bio-manufacturing skid market consists of sales of bioprocessing equipment, monitoring and control systems, sensors, pumps, tubing assemblies, valves, mixing systems, and control panels. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Continuous Bio-Manufacturing Skid Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses continuous bio-manufacturing skid market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for continuous bio-manufacturing skid ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The continuous bio-manufacturing skid market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Product Type: Single-Use Skids; Multi-Use Skids; Modular Skids
  • 2) By Process: Upstream; Downstream; Integrated
  • 3) By Application: Biopharmaceutical Production; Vaccine Manufacturing; Enzyme Production; Cell And Gene Therapy; Other Applications
  • 4) By End-User: Pharmaceutical Companies; Biotechnology Companies; Contract Manufacturing Organizations; Research Institutes; Other End-Users
  • Subsegments:
  • 1) By Single-Use Skids: Perfusion Bioreactor Skid; Tangential Flow Filtration Skid; Chromatography Skid; Buffer Preparation Skid
  • 2) By Multi-Use Skids: Fed-Batch Bioreactor Skid; Downstream Purification Skid; Ultrafiltration Skid; Viral Inactivation Skid
  • 3) By Modular Skid: Plug And Play Bioreactor Skid; Integrated Downstream Skid; Automated Sampling Skid; Real-Time Monitoring Skid
  • Companies Mentioned: Thermo Fisher Scientific Inc.; Danaher Corporation; Merck KGaA; Garrett Industrial Systems Ltd.; Sartorius AG; Getinge AB; ZETA GmbH; Pall Corporation; Repligen Corporation; ABEC Inc.; Enzene Biosciences Limited; Pierre Guerin Technologies; Bioengineering AG; KeyPlants GmbH; G&G Technologies Pvt. Ltd.; Scigenics Pvt. Ltd; Exentec B.V.; PAK BioSolutions Inc.; Stobbe Pharma GmbH; CPi Biotech Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Continuous Bio-Manufacturing Skid Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Continuous Bio-Manufacturing Skid Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Continuous Bio-Manufacturing Skid Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Continuous Bio-Manufacturing Skid Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Industry 4.0 & Intelligent Manufacturing
    • 4.1.3 Artificial Intelligence & Autonomous Intelligence
    • 4.1.4 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
    • 4.1.5 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.2. Major Trends
    • 4.2.1 Increasing Adoption Of Continuous And Integrated Bioprocessing Skids
    • 4.2.2 Rising Demand For Modular And Plug-And-Play Manufacturing Systems
    • 4.2.3 Growing Use Of Real-Time Process Monitoring And Control
    • 4.2.4 Expansion Of Single-Use Continuous Biomanufacturing Platforms
    • 4.2.5 Enhanced Focus On Process Efficiency And Throughput

5. Continuous Bio-Manufacturing Skid Market Analysis Of End Use Industries

  • 5.1 Pharmaceutical Companies
  • 5.2 Biotechnology Companies
  • 5.3 Contract Manufacturing Organizations
  • 5.4 Research Institutes
  • 5.5 Vaccine Manufacturers

6. Continuous Bio-Manufacturing Skid Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Continuous Bio-Manufacturing Skid Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Continuous Bio-Manufacturing Skid PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Continuous Bio-Manufacturing Skid Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Continuous Bio-Manufacturing Skid Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Continuous Bio-Manufacturing Skid Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Continuous Bio-Manufacturing Skid Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Continuous Bio-Manufacturing Skid Market Segmentation

  • 9.1. Global Continuous Bio-Manufacturing Skid Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Single-Use Skids, Multi-Use Skids, Modular Skids
  • 9.2. Global Continuous Bio-Manufacturing Skid Market, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Upstream, Downstream, Integrated
  • 9.3. Global Continuous Bio-Manufacturing Skid Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Biopharmaceutical Production, Vaccine Manufacturing, Enzyme Production, Cell And Gene Therapy, Other Applications
  • 9.4. Global Continuous Bio-Manufacturing Skid Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Pharmaceutical Companies, Biotechnology Companies, Contract Manufacturing Organizations, Research Institutes, Other End-Users
  • 9.5. Global Continuous Bio-Manufacturing Skid Market, Sub-Segmentation Of Single-Use Skids, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Perfusion Bioreactor Skid, Tangential Flow Filtration Skid, Chromatography Skid, Buffer Preparation Skid
  • 9.6. Global Continuous Bio-Manufacturing Skid Market, Sub-Segmentation Of Multi-Use Skids, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Fed-Batch Bioreactor Skid, Downstream Purification Skid, Ultrafiltration Skid, Viral Inactivation Skid
  • 9.7. Global Continuous Bio-Manufacturing Skid Market, Sub-Segmentation Of Modular Skid, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Plug And Play Bioreactor Skid, Integrated Downstream Skid, Automated Sampling Skid, Real-Time Monitoring Skid

10. Continuous Bio-Manufacturing Skid Market Regional And Country Analysis

  • 10.1. Global Continuous Bio-Manufacturing Skid Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Continuous Bio-Manufacturing Skid Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Continuous Bio-Manufacturing Skid Market

  • 11.1. Asia-Pacific Continuous Bio-Manufacturing Skid Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Continuous Bio-Manufacturing Skid Market, Segmentation By Product Type, Segmentation By Process, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Continuous Bio-Manufacturing Skid Market

  • 12.1. China Continuous Bio-Manufacturing Skid Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Continuous Bio-Manufacturing Skid Market, Segmentation By Product Type, Segmentation By Process, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Continuous Bio-Manufacturing Skid Market

  • 13.1. India Continuous Bio-Manufacturing Skid Market, Segmentation By Product Type, Segmentation By Process, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Continuous Bio-Manufacturing Skid Market

  • 14.1. Japan Continuous Bio-Manufacturing Skid Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Continuous Bio-Manufacturing Skid Market, Segmentation By Product Type, Segmentation By Process, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Continuous Bio-Manufacturing Skid Market

  • 15.1. Australia Continuous Bio-Manufacturing Skid Market, Segmentation By Product Type, Segmentation By Process, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Continuous Bio-Manufacturing Skid Market

  • 16.1. Indonesia Continuous Bio-Manufacturing Skid Market, Segmentation By Product Type, Segmentation By Process, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Continuous Bio-Manufacturing Skid Market

  • 17.1. South Korea Continuous Bio-Manufacturing Skid Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Continuous Bio-Manufacturing Skid Market, Segmentation By Product Type, Segmentation By Process, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Continuous Bio-Manufacturing Skid Market

  • 18.1. Taiwan Continuous Bio-Manufacturing Skid Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Continuous Bio-Manufacturing Skid Market, Segmentation By Product Type, Segmentation By Process, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Continuous Bio-Manufacturing Skid Market

  • 19.1. South East Asia Continuous Bio-Manufacturing Skid Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Continuous Bio-Manufacturing Skid Market, Segmentation By Product Type, Segmentation By Process, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Continuous Bio-Manufacturing Skid Market

  • 20.1. Western Europe Continuous Bio-Manufacturing Skid Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Continuous Bio-Manufacturing Skid Market, Segmentation By Product Type, Segmentation By Process, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Continuous Bio-Manufacturing Skid Market

  • 21.1. UK Continuous Bio-Manufacturing Skid Market, Segmentation By Product Type, Segmentation By Process, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Continuous Bio-Manufacturing Skid Market

  • 22.1. Germany Continuous Bio-Manufacturing Skid Market, Segmentation By Product Type, Segmentation By Process, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Continuous Bio-Manufacturing Skid Market

  • 23.1. France Continuous Bio-Manufacturing Skid Market, Segmentation By Product Type, Segmentation By Process, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Continuous Bio-Manufacturing Skid Market

  • 24.1. Italy Continuous Bio-Manufacturing Skid Market, Segmentation By Product Type, Segmentation By Process, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Continuous Bio-Manufacturing Skid Market

  • 25.1. Spain Continuous Bio-Manufacturing Skid Market, Segmentation By Product Type, Segmentation By Process, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Continuous Bio-Manufacturing Skid Market

  • 26.1. Eastern Europe Continuous Bio-Manufacturing Skid Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Continuous Bio-Manufacturing Skid Market, Segmentation By Product Type, Segmentation By Process, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Continuous Bio-Manufacturing Skid Market

  • 27.1. Russia Continuous Bio-Manufacturing Skid Market, Segmentation By Product Type, Segmentation By Process, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Continuous Bio-Manufacturing Skid Market

  • 28.1. North America Continuous Bio-Manufacturing Skid Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Continuous Bio-Manufacturing Skid Market, Segmentation By Product Type, Segmentation By Process, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Continuous Bio-Manufacturing Skid Market

  • 29.1. USA Continuous Bio-Manufacturing Skid Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Continuous Bio-Manufacturing Skid Market, Segmentation By Product Type, Segmentation By Process, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Continuous Bio-Manufacturing Skid Market

  • 30.1. Canada Continuous Bio-Manufacturing Skid Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Continuous Bio-Manufacturing Skid Market, Segmentation By Product Type, Segmentation By Process, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Continuous Bio-Manufacturing Skid Market

  • 31.1. South America Continuous Bio-Manufacturing Skid Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Continuous Bio-Manufacturing Skid Market, Segmentation By Product Type, Segmentation By Process, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Continuous Bio-Manufacturing Skid Market

  • 32.1. Brazil Continuous Bio-Manufacturing Skid Market, Segmentation By Product Type, Segmentation By Process, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Continuous Bio-Manufacturing Skid Market

  • 33.1. Middle East Continuous Bio-Manufacturing Skid Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Continuous Bio-Manufacturing Skid Market, Segmentation By Product Type, Segmentation By Process, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Continuous Bio-Manufacturing Skid Market

  • 34.1. Africa Continuous Bio-Manufacturing Skid Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Continuous Bio-Manufacturing Skid Market, Segmentation By Product Type, Segmentation By Process, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Continuous Bio-Manufacturing Skid Market Regulatory and Investment Landscape

36. Continuous Bio-Manufacturing Skid Market Competitive Landscape And Company Profiles

  • 36.1. Continuous Bio-Manufacturing Skid Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Continuous Bio-Manufacturing Skid Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Continuous Bio-Manufacturing Skid Market Company Profiles
    • 36.3.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Garrett Industrial Systems Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Sartorius AG Overview, Products and Services, Strategy and Financial Analysis

37. Continuous Bio-Manufacturing Skid Market Other Major And Innovative Companies

  • Getinge AB, ZETA GmbH, Pall Corporation, Repligen Corporation, ABEC Inc., Enzene Biosciences Limited, Pierre Guerin Technologies, Bioengineering AG, KeyPlants GmbH, G&G Technologies Pvt. Ltd., Scigenics Pvt. Ltd, Exentec B.V., PAK BioSolutions Inc., Stobbe Pharma GmbH, CPi Biotech Inc.

38. Global Continuous Bio-Manufacturing Skid Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Continuous Bio-Manufacturing Skid Market

40. Continuous Bio-Manufacturing Skid Market High Potential Countries, Segments and Strategies

  • 40.1 Continuous Bio-Manufacturing Skid Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Continuous Bio-Manufacturing Skid Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Continuous Bio-Manufacturing Skid Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제